Commerzbank Aktiengesellschaft’s Ionis Pharmaceuticals IONS Stock Holding History

Commerzbank Aktiengesellschaft’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-8,966	Closed	-$209	–	971
2016 Q2	$209	Buy	8,966 +140	+2%	+$4.52K	﹤0.01%	923
2016 Q1	$357K	Sell	8,826 -524	-6%	-$21.3K	﹤0.01%	804
2015 Q4	$579K	Buy	9,350 +91	+1%	+$4.91K	﹤0.01%	823
2015 Q3	$374K	Sell	9,259 -4,901	-35%	-$254K	﹤0.01%	891
2015 Q2	$815K	Buy	14,160 +1,848	+15%	+$118K	﹤0.01%	868
2015 Q1	$784K	Buy	+12,312	New	+$835K	﹤0.01%	851
2014 Q4	–	Sell	-5,254	Closed	-$204K	–	1176
2014 Q3	$204K	Buy	+5,254	New	+$186K	﹤0.01%	1081

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Commerzbank Aktiengesellschaft's IONS Position: Q3 2016 in Review

Commerzbank Aktiengesellschaft sold out of Ionis Pharmaceuticals (IONS) in Q3 2016, closing a stake of 8,966 shares — an estimated $209 sold.

Commerzbank Aktiengesellschaft first reported a position in IONS in Q3 2014 and held it in 7 quarters. The position peaked at $815K in Q2 2015. 281 funds tracked by Wall St. Rank hold IONS as of Q3 2016.

Commerzbank Aktiengesellschaft reported no remaining Ionis Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
Commerzbank Aktiengesellschaft sold 8,966 Ionis Pharmaceuticals shares in Q3 2016, an estimated $209.
Commerzbank Aktiengesellschaft first reported a position in Ionis Pharmaceuticals in Q3 2014 and held it in 7 quarters.
Commerzbank Aktiengesellschaft's Ionis Pharmaceuticals position peaked at $815K in Q2 2015.
281 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2016.

Based on Commerzbank Aktiengesellschaft's 13F filing for Q3 2016, filed 14 Nov 2016.